427 related articles for article (PubMed ID: 28035989)
21. Molecular targeting therapies for neuroblastoma: Progress and challenges.
Zafar A; Wang W; Liu G; Wang X; Xian W; McKeon F; Foster J; Zhou J; Zhang R
Med Res Rev; 2021 Mar; 41(2):961-1021. PubMed ID: 33155698
[TBL] [Abstract][Full Text] [Related]
22. Neuroblastoma models for insights into tumorigenesis and new therapies.
Kiyonari S; Kadomatsu K
Expert Opin Drug Discov; 2015 Jan; 10(1):53-62. PubMed ID: 25345447
[TBL] [Abstract][Full Text] [Related]
23. Genetic discoveries and treatment advances in neuroblastoma.
Bagatell R; Cohn SL
Curr Opin Pediatr; 2016 Feb; 28(1):19-25. PubMed ID: 26576010
[TBL] [Abstract][Full Text] [Related]
24. Neuroblastoma: an enigmatic disease.
Brossard J; Bernstein ML; Lemieux B
Br Med Bull; 1996 Oct; 52(4):787-801. PubMed ID: 9039732
[TBL] [Abstract][Full Text] [Related]
25. Recent biologic and genetic advances in neuroblastoma: Implications for diagnostic, risk stratification, and treatment strategies.
Newman EA; Nuchtern JG
Semin Pediatr Surg; 2016 Oct; 25(5):257-264. PubMed ID: 27955728
[TBL] [Abstract][Full Text] [Related]
26. The molecular basis of tumor metastasis and current approaches to decode targeted migration-promoting events in pediatric neuroblastoma.
Corallo D; Dalla Vecchia M; Lazic D; Taschner-Mandl S; Biffi A; Aveic S
Biochem Pharmacol; 2023 Sep; 215():115696. PubMed ID: 37481138
[TBL] [Abstract][Full Text] [Related]
27. A finite mixture survival model to characterize risk groups of neuroblastoma.
Hunsberger S; Albert PS; London WB
Stat Med; 2009 Apr; 28(8):1301-14. PubMed ID: 19184977
[TBL] [Abstract][Full Text] [Related]
28. At the frontier of progress for paediatric oncology: the neuroblastoma paradigm.
Moreno L; Marshall LV; Pearson AD
Br Med Bull; 2013; 108():173-88. PubMed ID: 24211816
[TBL] [Abstract][Full Text] [Related]
29. Neuroblastoma: the result of multistep transformation?
Tonini GP
Stem Cells; 1993 Jul; 11(4):276-82. PubMed ID: 8401251
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia in the Initiation and Progression of Neuroblastoma Tumours.
Huertas-Castaño C; Gómez-Muñoz MA; Pardal R; Vega FM
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861671
[TBL] [Abstract][Full Text] [Related]
31. Genomic medicine and neuroblastoma.
Oppenheimer O; Alaminos M; Gerald WL
Expert Rev Mol Diagn; 2003 Jan; 3(1):39-54. PubMed ID: 12528363
[TBL] [Abstract][Full Text] [Related]
32. Clinical Impact of Tumor Mutational Burden in Neuroblastoma.
Hwang WL; Wolfson RL; Niemierko A; Marcus KJ; DuBois SG; Haas-Kogan D
J Natl Cancer Inst; 2019 Jul; 111(7):695-699. PubMed ID: 30307503
[TBL] [Abstract][Full Text] [Related]
33. Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.
Pelizzo G; Veschi V; Mantelli M; Croce S; Di Benedetto V; D'Angelo P; Maltese A; Catenacci L; Apuzzo T; Scavo E; Moretta A; Todaro M; Stassi G; Avanzini MA; Calcaterra V
BMC Cancer; 2018 Nov; 18(1):1176. PubMed ID: 30482160
[TBL] [Abstract][Full Text] [Related]
34. CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours.
Vega FM; Colmenero-Repiso A; Gómez-Muñoz MA; Rodríguez-Prieto I; Aguilar-Morante D; Ramírez G; Márquez C; Cabello R; Pardal R
EBioMedicine; 2019 Nov; 49():82-95. PubMed ID: 31685444
[TBL] [Abstract][Full Text] [Related]
35. Research progress of neuroblastoma related gene variations.
Cao Y; Jin Y; Yu J; Wang J; Yan J; Zhao Q
Oncotarget; 2017 Mar; 8(11):18444-18455. PubMed ID: 28055978
[TBL] [Abstract][Full Text] [Related]
36. Zebrafish as a model to study neuroblastoma development.
Casey MJ; Stewart RA
Cell Tissue Res; 2018 May; 372(2):223-232. PubMed ID: 29027617
[TBL] [Abstract][Full Text] [Related]
37.
Yogev O; Almeida GS; Barker KT; George SL; Kwok C; Campbell J; Zarowiecki M; Kleftogiannis D; Smith LM; Hallsworth A; Berry P; Möcklinghoff T; Webber HT; Danielson LS; Buttery B; Calton EA; da Costa BM; Poon E; Jamin Y; Lise S; Veal GJ; Sebire N; Robinson SP; Anderson J; Chesler L
Cancer Res; 2019 Oct; 79(20):5382-5393. PubMed ID: 31405846
[TBL] [Abstract][Full Text] [Related]
38. Using big data in pediatric oncology: Current applications and future directions.
Major A; Cox SM; Volchenboum SL
Semin Oncol; 2020 Feb; 47(1):56-64. PubMed ID: 32229032
[TBL] [Abstract][Full Text] [Related]
39. An overview of neuroblastoma cell lineage phenotypes and
Campos Cogo S; Gradowski Farias da Costa do Nascimento T; de Almeida Brehm Pinhatti F; de França Junior N; Santos Rodrigues B; Cavalli LR; Elifio-Esposito S
Exp Biol Med (Maywood); 2020 Dec; 245(18):1637-1647. PubMed ID: 32787463
[TBL] [Abstract][Full Text] [Related]
40. Targets and Antibody Formats for Immunotherapy of Neuroblastoma.
Park JA; Cheung NV
J Clin Oncol; 2020 Jun; 38(16):1836-1848. PubMed ID: 32167865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
